Discord among Performance Measures for Central Line-Associated Bloodstream Infection

被引:8
|
作者
Tehrani, David M. [1 ,2 ]
Russell, Dana [3 ]
Brown, Jennifer [4 ]
Boynton-Delahanty, Kim [5 ,6 ]
Quan, Kathleen [7 ]
Gibbs, Laurel [8 ]
Braddock, Geri [3 ]
Zaroda, Teresa [3 ]
Koopman, Marsha [4 ]
Thompson, Deborah [7 ]
Nichols, Amy [8 ]
Cui, Eric [1 ,2 ]
Liu, Catherine [9 ]
Cohen, Stuart [4 ]
Rubin, Zachary [3 ]
Pegues, David [3 ]
Torriani, Francesca [5 ,6 ]
Datta, Rupak [1 ,2 ]
Huang, Susan S. [1 ,2 ,7 ]
机构
[1] Univ Calif Irvine, Sch Med, Div Infect Dis, Irvine, CA 92617 USA
[2] Univ Calif Irvine, Sch Med, Hlth Policy Res Inst, Irvine, CA 92617 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA
[4] Univ Calif Davis, Med Ctr, Div Infect & Immunol Dis, Sacramento, CA 95817 USA
[5] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Infect Prevent & Clin Epidemiol Unit, San Diego, CA 92103 USA
[7] Univ Calif Irvine Hlth, Epidemiol & Infect Prevent Program, Orange, CA USA
[8] Univ Calif San Francisco, Med Ctr, Dept Hosp Epidemiol & Infect Control, San Francisco, CA USA
[9] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA
来源
基金
美国国家卫生研究院;
关键词
CARE; SURVEILLANCE; QUALITY; SAFETY;
D O I
10.1086/669090
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Central line-associated bloodstream infection (CLABSI) is a national target for mandatory reporting and a Centers for Medicare and Medicaid Services target for value-based purchasing. Differences in chart review versus claims-based metrics used by national agencies and groups raise concerns about the validity of these measures. OBJECTIVE. Evaluate consistency and reasons for discordance among chart review and claims-based CLABSI events. METHODS. We conducted 2 multicenter retrospective cohort studies within 6 academic institutions. A total of 150 consecutive patients were identified with CLABSI on the basis of National Healthcare Safety Network (NHSN) criteria (NHSN cohort), and an additional 150 consecutive patients were identified with CLABSI on the basis of claims codes (claims cohort). All events had full-text medical record reviews and were identified as concordant or discordant with the other metric. RESULTS. In the NHSN cohort, there were 152 CLABSIs among 150 patients, and 73.0% of these cases were discordant with claims data. Common reasons for the lack of associated claims codes included coding omission and lack of physician documentation of bacteremia cause. In the claims cohort, there were 150 CLABSIs among 150 patients, and 65.3% of these cases were discordant with NHSN criteria. Common reasons for the lack of NHSN reporting were identification of non-CLABSI with bacteremia meeting Centers for Disease Control and Prevention (CDC) criteria for an alternative infection source. CONCLUSION. Substantial discordance between NHSN and claims-based CLABSI indicators persists. Compared with standardized CDC chart review criteria, claims data often had both coding omissions and misclassification of non-CLABSI infections as CLABSI. Additionally, claims did not identify any additional CLABSIs for CDC reporting. NHSN criteria are a more consistent interhospital standard for CLABSI reporting. Infect Control Hosp Epidemiol 2013; 34(2): 176-183
引用
收藏
页码:176 / 183
页数:8
相关论文
共 50 条
  • [1] Central line-associated bloodstream infection prevention
    Miller, Sarah E.
    Maragakis, Lisa L.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (04) : 412 - 422
  • [2] The impact of central line insertion bundle on central line-associated bloodstream infection
    Tang, Hung-Jen
    Lin, Hsin-Lan
    Lin, Yu-Hsiu
    Leung, Pak-On
    Chuang, Yin-Ching
    Lai, Chih-Cheng
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [3] The impact of central line insertion bundle on central line-associated bloodstream infection
    Hung-Jen Tang
    Hsin-Lan Lin
    Yu-Hsiu Lin
    Pak-On Leung
    Yin-Ching Chuang
    Chih-Cheng Lai
    [J]. BMC Infectious Diseases, 14
  • [4] The Association Between Central Line-Associated Bloodstream Infection and Central Line Access*
    Ward, Andrew
    Chemparathy, Augustine
    Seneviratne, Martin
    Gaskari, Shabnam
    Mathew, Roshni
    Wood, Matthew
    Donnelly, Lane F.
    Lee, Grace M.
    Scheinker, David
    Shin, Andrew Y.
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (06) : 787 - 796
  • [5] Preventing Central Line-Associated Bloodstream Infection In Reply to Mermel
    Bonne, Stephanie
    Mazuski, John E.
    Schuerer, Douglas J. E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : 892 - 893
  • [6] eNews Tool to Prevent Central Line-Associated Bloodstream Infection
    Morrison, Theresa
    [J]. CIN-COMPUTERS INFORMATICS NURSING, 2018, 36 (04) : 161 - 165
  • [7] A Tiered Approach for Preventing Central Line-Associated Bloodstream Infection
    Patel, Payal K.
    Olmsted, Russell N.
    Hung, Louella
    Popovich, Kyle J.
    Meddings, Jennifer
    Jones, Karen
    Calfee, David P.
    Fowler, Karen E.
    Saint, Sanjay
    Chopra, Vineet
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 171 (07) : S16 - U123
  • [8] Central Line-associated Bloodstream Infection in Children: An Update on Treatment
    Wolf, Joshua
    Curtis, Nigel
    Worth, Leon J.
    Flynn, Patricia M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (08) : 905 - 910
  • [10] Effectiveness of a bundle of measures for reducing central line-associated bloodstream infections
    Hernandez-Aceituno, A.
    Vega-Costa, V.
    Ruiz-Alvarez, M.
    Figuerola-Tejerina, A.
    Mendez-Hernandez, R.
    Ramasco-Rueda, F.
    [J]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2020, 67 (05): : 227 - 236